BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 6899978)

  • 21. Separation of six bovine complement components and one inactivator (1, 2).
    Barta O; Nelson RA; Kuo CY
    Immunol Commun; 1976; 5(1-2):75-86. PubMed ID: 950248
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Purification and quantitation of the components of the alternative complement pathway.
    Minta JO; Gee AP
    Methods Enzymol; 1983; 93():375-408. PubMed ID: 6223199
    [No Abstract]   [Full Text] [Related]  

  • 23. Alternative pathway of complement.
    Pangburn MK
    Methods Enzymol; 1988; 162():639-53. PubMed ID: 2976114
    [No Abstract]   [Full Text] [Related]  

  • 24. Increased ion permeability of planar lipid bilayer membranes after treatment with the C5b-9 cytolytic attack mechanism of complement.
    Michaels DW; Abramovitz AS; Hammer CH; Mayer MM
    Proc Natl Acad Sci U S A; 1976 Aug; 73(8):2852-6. PubMed ID: 1066698
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Raji cell injury and subsequent lysis by the purified cytolytic alternative pathway of human complement.
    Schreiber RD; Pangburn MK; Medicus RG; Müller-Eberhard HJ
    Clin Immunol Immunopathol; 1980 Mar; 15(3):384-96. PubMed ID: 6899978
    [No Abstract]   [Full Text] [Related]  

  • 26. Formation and function of the classical and alternative pathways of complement.
    Ogle JD; Ogle CK
    Clin Physiol Biochem; 1983; 1(2-5):194-213. PubMed ID: 6241120
    [No Abstract]   [Full Text] [Related]  

  • 27. Activation of the alternative complement pathway.
    Fearon DT
    CRC Crit Rev Immunol; 1979 Nov; 1(1):1-32. PubMed ID: 162484
    [No Abstract]   [Full Text] [Related]  

  • 28. The properdin pathway: mechanisms of complement activation and analogies to the classical pathway.
    Fearon DT; Austen KF; Ruddy S
    Rheumatology; 1975; 6():2-16. PubMed ID: 1105744
    [No Abstract]   [Full Text] [Related]  

  • 29. Functional active complement components secreted by guinea pig peritoneal macrophages.
    Brade V; Kreuzpaintner G
    Immunobiology; 1982 Apr; 161(3-4):315-21. PubMed ID: 7047377
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The alternative complement pathway].
    Jouvin MH; Kazatchkine M
    Pathol Biol (Paris); 1983 Dec; 31(10):839-46. PubMed ID: 6230588
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Alternative complement pathway].
    Jouvin MH; Kazatchkine M
    Sem Hop; 1984 May; 60(19):1371-8. PubMed ID: 6326330
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Alternative complement pathway (author's transl)].
    Kazatchkine M; Nydegger U; Fearon DT
    Nouv Presse Med; 1979 Jun; 8(26):2187-94. PubMed ID: 382108
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Complement: activation, consequences, and control.
    James K
    Am J Med Technol; 1982 Sep; 48(9):735-42. PubMed ID: 6215861
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytotoxic action and other metabolic consequences of terminal complement proteins.
    Shin ML; Carney DF
    Prog Allergy; 1988; 40():44-81. PubMed ID: 3281171
    [No Abstract]   [Full Text] [Related]  

  • 35. Complement.
    Müller-Eberhard HJ
    Annu Rev Biochem; 1975; 44():697-724. PubMed ID: 1094920
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.